-+ 0.00%
-+ 0.00%
-+ 0.00%

FRACTYL HEALTH,.: TO DISCONTINUE INTERNAL DEVELOPMENT OF ITS REJUVA GENE THERAPY PROGRAM ,SEEKING STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE OF PROGRAM

Reuters·10/22/2026 11:00:00

Please log in to view news